| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
1,770,000,000 |
| Market
Cap: |
286.01(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$132.51 - $182.1 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 560 |
| Guru Rank Value : 3 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and Juvederm Collection; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon, Lupron, and Synthroid.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
459,004 |
461,916 |
540,416 |
1,279,317 |
| Total Sell Value |
$81,195,771 |
$81,646,316 |
$93,320,391 |
$207,372,438 |
| Total People Sold |
9 |
9 |
9 |
14 |
| Total Sell Transactions |
10 |
11 |
13 |
34 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Saleki-Gerhardt Azita |
SVP, Operations |
• – – |
2017-09-11 |
4 |
OE |
$24.21 |
$116,199 |
D/D |
4,800 |
93,099 |
|
- |
|
| Schumacher Laura J |
Executive Vice President |
• – – |
2017-09-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,093 |
105,732 |
|
- |
|
| Gonzalez Richard A |
Chairman of the Board and CEO |
• • – |
2017-08-07 |
4 |
S |
$71.00 |
$13,713,186 |
D/D |
(193,131) |
276,492 |
|
- |
|
| Gonzalez Richard A |
Chairman of the Board and CEO |
• • – |
2017-08-07 |
4 |
OE |
$51.42 |
$9,930,796 |
D/D |
193,131 |
469,623 |
|
- |
|
| Gonzalez Richard A |
Chairman of the Board and CEO |
• • – |
2017-08-04 |
4 |
S |
$71.00 |
$1,566,166 |
D/D |
(22,038) |
276,492 |
|
- |
|
| Gonzalez Richard A |
Chairman of the Board and CEO |
• • – |
2017-08-04 |
4 |
OE |
$51.42 |
$1,133,194 |
D/D |
22,038 |
364,391 |
|
- |
|
| Gonzalez Richard A |
Chairman of the Board and CEO |
• • – |
2017-08-03 |
4 |
S |
$71.00 |
$4,676,131 |
D/D |
(65,861) |
298,530 |
|
- |
|
| Gonzalez Richard A |
Chairman of the Board and CEO |
• • – |
2017-08-03 |
4 |
OE |
$51.42 |
$3,386,573 |
D/D |
65,861 |
342,353 |
|
- |
|
| Gosebruch Henry O |
Chief Strategy Officer |
• – – |
2017-07-31 |
4 |
S |
$70.00 |
$1,261,638 |
D/D |
(18,000) |
83,737 |
|
- |
|
| Rapp Edward J |
Director |
– • – |
2017-07-31 |
4 |
B |
$70.45 |
$281,782 |
D/D |
4,000 |
15,498 |
2.39 |
- |
|
| Gosebruch Henry O |
Chief Strategy Officer |
• – – |
2017-07-31 |
4 |
S |
$70.45 |
$14,090 |
D/D |
(200) |
83,437 |
|
- |
|
| Gosebruch Henry O |
Chief Strategy Officer |
• – – |
2017-07-31 |
4 |
S |
$70.37 |
$7,037 |
D/D |
(100) |
83,637 |
|
- |
|
| Gonzalez Richard A |
Chairman of the Board and CEO |
• • – |
2017-06-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,235 |
276,492 |
|
- |
|
| Schumacher Laura J |
Executive Vice President |
• – – |
2017-06-14 |
4 |
S |
$70.00 |
$5,586,000 |
D/D |
(79,800) |
107,825 |
|
- |
|
| Schumacher Laura J |
Executive Vice President |
• – – |
2017-06-14 |
4 |
OE |
$29.23 |
$2,332,275 |
D/D |
79,800 |
187,625 |
|
- |
|
| Alban Carlos |
EVP, Commercial Operations |
• – – |
2017-06-14 |
4 |
S |
$70.00 |
$3,206,000 |
D/D |
(45,800) |
114,745 |
|
- |
|
| Alban Carlos |
EVP, Commercial Operations |
• – – |
2017-06-14 |
4 |
OE |
$24.21 |
$1,108,736 |
D/D |
45,800 |
160,545 |
|
- |
|
| Severino Michael |
EVP, R&D and CSO |
• – – |
2017-06-02 |
4 |
D |
$66.71 |
$1,439,335 |
D/D |
(21,576) |
140,555 |
|
- |
|
| Gonzalez Richard A |
Chairman of the Board and CEO |
• • – |
2017-05-19 |
4 |
S |
$65.44 |
$4,665,063 |
D/D |
(71,235) |
278,727 |
|
- |
|
| Chase William J |
EVP, Chief Financial Officer |
• – – |
2017-05-18 |
4 |
S |
$65.35 |
$2,502,905 |
D/D |
(38,300) |
183,543 |
|
- |
|
| Chase William J |
EVP, Chief Financial Officer |
• – – |
2017-05-18 |
4 |
OE |
$28.13 |
$1,095,994 |
D/D |
38,300 |
221,843 |
|
- |
|
| Liddy Edward M |
Director |
– • – |
2017-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,770 |
18,351 |
|
- |
|
| Alpern Robert J |
Director |
– • – |
2017-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,770 |
21,789 |
|
- |
|
| Hart Brett J |
Director |
– • – |
2017-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,770 |
5,744 |
|
- |
|
| Tilton Glenn F |
Director |
– • – |
2017-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,770 |
32,436 |
|
- |
|
641 Records found
|
|
Page 20 of 26 |
|
|
0.31 (0.19%) 
